Akebia Therapeutics dba Keryx Biopharmaceutials, Inc recalls Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufactured for and distributed by: KERYX BIOP…

Recall date

January 29, 2021

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0260-2021

FDA classification

Class III

Brand / firm

Akebia Therapeutics dba Keryx Biopharmaceutials, Inc

Sold / distributed

Nationwide.

Why it was recalled

Failed Dissolution Specifications

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., 245 First Street, Suite 1400, Cambridge, MA 02142, USA, NDC 59922-0631-01.